Elevance Health Gross Profit 2012-2025 | ELV
Elevance Health annual/quarterly gross profit history and growth rate from 2012 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- Elevance Health gross profit for the quarter ending September 30, 2025 was $7.191B, a 1.8% increase year-over-year.
- Elevance Health gross profit for the twelve months ending September 30, 2025 was $29.494B, a 2.47% decline year-over-year.
- Elevance Health annual gross profit for 2024 was $29.694B, a 0.08% decline from 2023.
- Elevance Health annual gross profit for 2023 was $29.717B, a 10.4% increase from 2022.
- Elevance Health annual gross profit for 2022 was $26.918B, a 6.93% increase from 2021.
|
Elevance Health Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $29,694 |
| 2023 | $29,717 |
| 2022 | $26,918 |
| 2021 | $25,173 |
| 2020 | $24,869 |
| 2019 | $20,435 |
| 2018 | $20,210 |
| 2017 | $17,804 |
| 2016 | $18,029 |
| 2015 | $18,040 |
| 2014 | $17,019 |
| 2013 | $14,786 |
| 2012 | $13,284 |
| 2011 | $13,063 |
|
Elevance Health Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-09-30 | $7,191 |
| 2025-06-30 | $7,777 |
| 2025-03-31 | $8,596 |
| 2024-12-31 | $5,930 |
| 2024-09-30 | $7,064 |
| 2024-06-30 | $8,494 |
| 2024-03-31 | $8,206 |
| 2023-12-31 | $6,476 |
| 2023-09-30 | $7,595 |
| 2023-06-30 | $7,741 |
| 2023-03-31 | $7,905 |
| 2022-12-31 | $6,088 |
| 2022-09-30 | $7,081 |
| 2022-06-30 | $6,768 |
| 2022-03-31 | $6,981 |
| 2021-12-31 | $6,047 |
| 2021-09-30 | $6,279 |
| 2021-06-30 | $6,474 |
| 2021-03-31 | $6,373 |
| 2020-12-31 | $5,214 |
| 2020-09-30 | $6,015 |
| 2020-06-30 | $7,492 |
| 2020-03-31 | $6,148 |
| 2019-12-31 | $4,875 |
| 2019-09-30 | $5,176 |
| 2019-06-30 | $5,000 |
| 2019-03-31 | $5,384 |
| 2018-12-31 | $4,437 |
| 2018-09-30 | $5,066 |
| 2018-06-30 | $5,216 |
| 2018-03-31 | $5,491 |
| 2017-12-31 | $4,009 |
| 2017-09-30 | $4,322 |
| 2017-06-30 | $4,490 |
| 2017-03-31 | $4,983 |
| 2016-12-31 | $4,147 |
| 2016-09-30 | $4,481 |
| 2016-06-30 | $4,651 |
| 2016-03-31 | $4,750 |
| 2015-12-31 | $3,872 |
| 2015-09-30 | $4,433 |
| 2015-06-30 | $4,810 |
| 2015-03-31 | $4,925 |
| 2014-12-31 | $4,126 |
| 2014-09-30 | $4,346 |
| 2014-06-30 | $4,352 |
| 2014-03-31 | $4,195 |
| 2013-12-31 | $3,321 |
| 2013-09-30 | $3,781 |
| 2013-06-30 | $3,858 |
| 2013-03-31 | $3,827 |
| 2012-12-31 | $3,031 |
| 2012-09-30 | $3,302 |
| 2012-06-30 | $3,308 |
| 2012-03-31 | $3,643 |
| 2011-12-31 | $2,883 |
| 2011-09-30 | $3,335 |
| 2011-06-30 | $3,179 |
| 2011-03-31 | $3,666 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $83.311B | $177.011B |
| Elevance Health Inc. operates as a health benefits company. It supports consumers, families and communities across the entire care journey connecting to the care, support and resources to lead healthier lives. Elevance Health Inc., formerly known as Anthem Inc., is based in Indianapolis, Indiana. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $166.692B | 30.61 |
| HCA Healthcare (HCA) | United States | $107.089B | 17.73 |
| CVS Health (CVS) | United States | $99.777B | 11.47 |
| Cencora (COR) | United States | $68.838B | 22.19 |
| Natera (NTRA) | United States | $31.987B | 0.00 |
| DiDi Global (DIDIY) | China | $23.485B | 21.70 |
| Labcorp Holdings (LH) | United States | $22.455B | 17.12 |
| Medpace Holdings (MEDP) | United States | $17.208B | 42.72 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.445B | 0.00 |
| Viatris (VTRS) | United States | $14.812B | 5.52 |
| BioMerieux (BMXMF) | France | $14.802B | 0.00 |
| ICON (ICLR) | Ireland | $14.747B | 14.63 |
| Solventum (SOLV) | United States | $13.786B | 13.38 |
| Revvity (RVTY) | United States | $12.755B | 23.49 |
| CochLear (CHEOY) | Australia | $11.760B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.813B | 20.82 |
| Avantor (AVTR) | United States | $8.291B | 12.67 |
| Sonic Healthcare (SKHHY) | Australia | $7.752B | 0.00 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.556B | 0.00 |
| HealthEquity (HQY) | United States | $7.294B | 27.27 |
| BrightSpring Health Services (BTSG) | United States | $7.070B | 42.15 |
| Bausch + Lomb (BLCO) | Canada | $6.078B | 39.91 |
| PACS (PACS) | United States | $6.072B | 36.92 |
| Sotera Health (SHC) | United States | $5.449B | 26.27 |
| Alignment Healthcare (ALHC) | United States | $4.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $3.719B | 21.70 |
| GeneDx Holdings (WGS) | United States | $3.124B | 54.86 |
| Concentras Parent (CON) | United States | $2.762B | 17.24 |
| Organon (OGN) | United States | $2.277B | 2.40 |
| Progyny (PGNY) | United States | $2.114B | 41.56 |
| Surgery Partners (SGRY) | United States | $2.057B | 26.50 |
| Establishment Labs Holdings (ESTA) | United States | $1.962B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.877B | 11.21 |
| Ardent Health (ARDT) | United States | $1.231B | 4.02 |
| Teladoc Health (TDOC) | United States | $1.115B | 0.00 |
| Nutex Health (NUTX) | United States | $1.080B | 8.26 |
| CareDx (CDNA) | United States | $1.029B | 16.82 |
| Omada Health (OMDA) | United States | $0.933B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $0.910B | 14.89 |
| InnovAge Holding (INNV) | United States | $0.794B | 0.00 |
| Embecta (EMBC) | United States | $0.734B | 4.17 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.706B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.594B | 0.00 |
| CryoPort (CYRX) | United States | $0.552B | 0.00 |
| Enhabit (EHAB) | United States | $0.532B | 23.91 |
| Strata Critical Medical (SRTA) | United States | $0.515B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.497B | 0.00 |
| SBC Medicals (SBC) | United States | $0.445B | 8.19 |
| Agilon Health (AGL) | United States | $0.423B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.343B | 5.51 |
| Oncology Institute (TOI) | United States | $0.330B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.288B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.279B | 58.75 |
| So-Young (SY) | China | $0.269B | 0.00 |
| KindlyMD (NAKA) | United States | $0.201B | 0.00 |
| Beauty Health (SKIN) | United States | $0.191B | 0.00 |
| LifeMD (LFMD) | United States | $0.181B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.141B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.139B | 0.00 |
| DocGo (DCGO) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.063B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.062B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.046B | 0.00 |
| Pomdoctor - (POM) | China | $0.030B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.020B | 6.21 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.018B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.016B | 0.00 |
| Lifeward (LFWD) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.003B | 0.00 |
| XWELL (XWEL) | United States | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.000B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |